Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of MP-513 in combination
with Metformin in patients with type 2 diabetes for 24 weeks administration and to evaluate
the safety and efficacy of MP-513 in combination with Metformin with an extension treatment
for up to 52 weeks.